Amlodipine Besylate Patent Expiration
Amlodipine Besylate was first introduced by Viatris Specialty Llc
Amlodipine Besylate Patents
Given below is the list of patents protecting Amlodipine Besylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Amlodipine Besylate | US6828339 | Amlodipine salt forms and processes for preparing them |
Nov 20, 2022
(Expired) | Synthon Pharms |
| Norliqva | US11253474 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
| Norliqva | US11458095 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
| Norliqva | US11723866 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
| Norliqva | US12005141 | Pharmaceutical solution of amlodipine | Feb 24, 2041 | Cmp Dev Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Amlodipine Besylate's patents.
Latest Legal Activities on Amlodipine Besylate's Patents
Given below is the list recent legal activities going on the following patents of Amlodipine Besylate.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Expire Patent | 07 Jan, 2013 | US6828339 |
| Change in Power of Attorney (May Include Associate POA) | 16 Apr, 2007 | US6828339 |
| Correspondence Address Change | 16 Apr, 2007 | US6828339 |
| Correspondence Address Change | 09 Mar, 2005 | US6828339 |
| Recordation of Patent Grant Mailed | 07 Dec, 2004 | US6828339 |
| Patent Issue Date Used in PTA Calculation | 07 Dec, 2004 | US6828339 |
| Issue Notification Mailed | 18 Nov, 2004 | US6828339 |
| Receipt into Pubs | 15 Nov, 2004 | US6828339 |
| Dispatch to FDC | 11 Nov, 2004 | US6828339 |
| Receipt into Pubs | 05 Nov, 2004 | US6828339 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Amlodipine Besylate Generics
Several generic applications have been filed for Amlodipine Besylate. The first generic version for Amlodipine Besylate was by Mylan Pharmaceuticals Inc and was approved on Oct 3, 2005. And the latest generic version is by Sunshine Lake Pharma Co Ltd and was approved on May 4, 2018.
Given below is the list of companies who have filed for Amlodipine Besylate generic.
1. OXFORD PHARMS
Oxford Pharmaceuticals Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Oxford Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Apr 7, 2010 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Apr 7, 2010 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Apr 7, 2010 |
2. LUPIN
Lupin Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | BX | Jul 12, 2007 |
| EQ 10MG BASE | tablet | Prescription | ORAL | BX | Jul 12, 2007 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | BX | Jul 12, 2007 |
3. INVAGEN PHARMS
Invagen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Invagen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Dec 10, 2015 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Dec 10, 2015 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Dec 10, 2015 |
4. TEVA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jun 28, 2007 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Jun 28, 2007 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Jun 28, 2007 |
5. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Jul 11, 2007 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Jul 11, 2007 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jul 11, 2007 |
6. ZYDUS PHARMS USA
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jul 9, 2007 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Jul 9, 2007 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Jul 9, 2007 |
7. UNICHEM
Unichem Laboratories Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Unichem.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Oct 21, 2013 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Oct 21, 2013 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Oct 21, 2013 |
8. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | May 4, 2018 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | May 4, 2018 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | May 4, 2018 |
9. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Jul 17, 2007 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jul 17, 2007 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Jul 17, 2007 |
10. SYNTHON PHARMS
Synthon Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Synthon Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jun 27, 2007 |
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jun 27, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jun 27, 2007 |
11. HIKMA PHARMS
Hikma Pharmaceuticals has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Hikma Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Apr 12, 2011 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Apr 12, 2011 |
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Apr 12, 2011 |
12. PURACAP PHARM
Puracap Pharmaceutical Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Puracap Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Sep 4, 2007 |
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 4, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 4, 2007 |
13. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Nov 30, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Nov 30, 2007 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Nov 30, 2007 |
14. TORRENT PHARMS
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Torrent Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 22, 2008 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Sep 22, 2008 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 22, 2008 |
15. CIPLA
Cipla Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 26, 2007 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Sep 26, 2007 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 26, 2007 |
16. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
17. GENPHARM
Genpharm Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Genpharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
18. WATSON LABS
Watson Laboratories Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 19, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 19, 2007 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jul 19, 2007 |
19. AMNEAL PHARMS NY
Amneal Pharmaceuticals Ny Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Ny.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jan 16, 2008 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jan 16, 2008 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jan 16, 2008 |
20. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
21. SOVEREIGN PHARMS
Sovereign Pharmaceuticals Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sovereign Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jul 23, 2015 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 23, 2015 |
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 23, 2015 |
22. GEDEON RICHTER USA
Gedeon Richter Usa Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Gedeon Richter Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jul 17, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 17, 2007 |
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 17, 2007 |
23. WOCKHARDT
Wockhardt Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Wockhardt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 6, 2007 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Sep 6, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 6, 2007 |
24. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Apr 29, 2013 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Apr 29, 2013 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Apr 29, 2013 |
25. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 10, 2007 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Sep 10, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 10, 2007 |
26. POLYGEN PHARMS
Polygen Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Polygen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Jul 11, 2016 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jul 11, 2016 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Jul 11, 2016 |
27. ALKEM
Alkem Laboratories Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Alkem.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | May 4, 2009 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | May 4, 2009 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | May 4, 2009 |
28. COREPHARMA
Corepharma Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Corepharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | May 23, 2007 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | May 23, 2007 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | May 23, 2007 |
29. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jan 31, 2008 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jan 31, 2008 |
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jan 31, 2008 |
30. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Apr 13, 2012 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Apr 13, 2012 |
31. CHINA RESOURCES
China Resources Saike Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by China Resources.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Apr 15, 2011 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Apr 15, 2011 |
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | May 16, 2016 |
32. AIPING PHARM INC
Aiping Pharmaceutical Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Jul 9, 2007 |
33. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2008 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2008 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Feb 27, 2008 |
34. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Jul 2, 2009 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Jul 2, 2009 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jul 2, 2009 |
35. EPIC PHARMA LLC
Epic Pharma Llc has filed for 3 different strengths of generic version for Amlodipine Besylate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2.5MG BASE | tablet | Prescription | ORAL | AB | Apr 8, 2009 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Apr 8, 2009 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Apr 8, 2009 |